Details for Patent: 6,319,913
✉ Email this page to a colleague
Summary for Patent: 6,319,913
Title: | Penetration enhancing and irritation reducing systems |
Abstract: | This invention lies in the technology of transdermal and topical drug delivery. In particular, the present invention relates to enhancement of the penetration of transdermally or topically applied drugs and with the reduction of skin irritation that often accompanies transdermal and topical drug delivery. |
Inventor(s): | Mak; Vivien H. W. (Menlo Park, CA), Grayson; Stephen (San Rafael, CA) |
Assignee: | Cellegy Pharmaceuticals, Inc. (South San Francisco, CA) |
Application Number: | 09/189,090 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,319,913 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 6,319,913
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,319,913
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 418988 | ⤷ Sign Up | |||
Australia | 1313299 | ⤷ Sign Up | |||
Australia | 747041 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |